Skip to main content
Clinical Trials/NCT06325241
NCT06325241
Active, Not Recruiting
N/A

Validating the Use of Frailty Measurements to Predict Care Expectations and Deteriorations in Quality of Life Among People With COPD: A Prospective Cohort Study

Ottawa Hospital Research Institute1 site in 1 country123 target enrollmentDecember 12, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Ottawa Hospital Research Institute
Enrollment
123
Locations
1
Primary Endpoint
Respiratory Health Related Quality of Life
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The aim of this research program is to validate frailty measurements as a risk stratification tool to predict deteriorations in patient-reported outcomes, to gain a better understanding of patient preferences for care within varying degrees of frailty, and to assess differences in frailty measurement between patients and their clinicians.

This work will provide a foundation in the development of customized interventions for people with COPD and varying degrees of frailty, with the goal of improving quality of life and optimizing health system service delivery for patients and their care givers.

Registry
clinicaltrials.gov
Start Date
December 12, 2022
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sunita Mulpuru

Staff Physician, Investigator

Ottawa Hospital Research Institute

Eligibility Criteria

Inclusion Criteria

  • Outpatients of The Ottawa Hospital Respirology clinic
  • Chronic Obstructive Pulmonary Disease diagnosis confirmed by pulmonary function testing.
  • English or French speaking

Exclusion Criteria

  • patients with a known diagnosis of severe cognitive impairment

Outcomes

Primary Outcomes

Respiratory Health Related Quality of Life

Time Frame: 12 months

measured by the validated short version of St. Georges Respiratory Questionnaire (not a scale).

Secondary Outcomes

  • Burden of symptoms - Dyspnea(12 months)
  • Psycho-social well being - Depression(12 months)
  • Burden of symptoms - COPD Assessment(12 months)
  • Psycho-social well being - Anxiety(12 months)

Study Sites (1)

Loading locations...

Similar Trials